Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - Loss AllowanceNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RedHill Biopharma (RDHL) Intangibles: 2011-2024

Historic Intangibles for RedHill Biopharma (RDHL) over the last 14 years, with Dec 2024 value amounting to $5.5 million.

  • RedHill Biopharma's Intangibles fell 0.56% to $5.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $5.5 million, marking a year-over-year decrease of 0.56%. This contributed to the annual value of $5.5 million for FY2024, which is 0.56% down from last year.
  • Latest data reveals that RedHill Biopharma reported Intangibles of $5.5 million as of FY2024, which was down 0.56% from $5.6 million recorded in FY2023.
  • Over the past 5 years, RedHill Biopharma's Intangibles peaked at $89.4 million during FY2020, and registered a low of $5.5 million during FY2024.
  • For the 3-year period, RedHill Biopharma's Intangibles averaged around $33.5 million, with its median value being $5.6 million (2023).
  • Its Intangibles has fluctuated over the past 5 years, first spiked by 658.17% in 2020, then slumped by 93.76% in 2023.
  • Yearly analysis of 5 years shows RedHill Biopharma's Intangibles stood at $89.4 million in 2020, then remained steady at $89.4 million in 2021, then remained steady at $89.4 million in 2022, then slumped by 93.76% to $5.6 million in 2023, then decreased by 0.56% to $5.5 million in 2024.